Keywords: Biomarkers, biomarkers, liver fibrosis, liver function, pharmacokinetic model
Motivation: Quantitatively assessing liver function and liver fibrosis is important for patients with chronic liver disease.
Goal(s): To evaluate the value of pharmacokinetic parameters derived from the dual-input dual-compartmental uptake and efflux model based on DCE-MRI for quantitatively assessing the liver function and liver fibrosis in a rat model.
Approach: The relationships between pharmacokinetic parameters and the expression of hepatic transporters and histopathological metrics (Sirius red and α-SMA-positive ratios) were analysed in a liver fibrosis rat model.
Results: Significant correlations were found between pharmacokinetic parameters and the expression of hepatic transporters. The diagnostic efficency of these parameters for staging liver fibrosis was satisfactory.
Impact: Our findings suggested that the parameters derived from the dual-input dual-compartmental uptake and efflux model were useful for assessing liver function and simultaneously evaluating the degree of liver fibrosis.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords